EP 1455819 A1 20040915 - INDIVIDUALIZED ANTI-CANCER ANTIBODIES
Title (en)
INDIVIDUALIZED ANTI-CANCER ANTIBODIES
Title (de)
INDIVIDUALISIERTE ANTIKÖRPER GEGEN KREBS
Title (fr)
ANTICORPS ANTICANCEREUX PERSONNALISES
Publication
Application
Priority
CA 0101838 W 20011221
Abstract (en)
[origin: WO03055515A1] The present invention relates to a method for producing patient specific anti-cancer antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as end point, the process makes possible the production of anti-cancer antibodies customized for the individual patient that can be used for therapeutic and diagnostic purposes.
IPC 1-7
IPC 8 full level
C12P 21/08 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 16/30 (2013.01); C07K 16/3015 (2013.01); C07K 16/3023 (2013.01); C07K 16/3053 (2013.01)
Citation (search report)
See references of WO 03055515A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03055515 A1 20030710; AU 2002226211 A1 20030715; CA 2471206 A1 20030710; EP 1455819 A1 20040915; JP 2005518393 A 20050623
DOCDB simple family (application)
CA 0101838 W 20011221; AU 2002226211 A 20011221; CA 2471206 A 20011221; EP 01995525 A 20011221; JP 2003556091 A 20011221